Treatment Patterns in Patients With Huntington's Disease or Tardive Dyskinesia Treated with Deutetrabenazine
Latest Information Update: 23 Oct 2020
At a glance
- Drugs Deutetrabenazine (Primary)
- Indications Drug-induced dyskinesia; Huntington's disease
- Focus Therapeutic Use
- 23 Oct 2020 New trial record
- 16 Sep 2020 Results presented at the 24th International Congress of Parkinson's Disease and Movement Disorders